Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:HWC
NasdaqGS:HWCBanks

Is It Too Late To Consider Hancock Whitney (HWC) After A 35% One Year Rally?

If you are wondering whether Hancock Whitney's recent share price puts it in bargain or fully priced territory, the valuation picture is the key piece to focus on next. Over the past year, the stock has returned 35.2%, with shorter term moves of 2.8% over 7 days, 8.2% over 30 days, and 6.5% year to date from a last close of US$68.62. Recent coverage around regional banks has kept attention on balance sheet strength, growth plans, and the interest rate backdrop. All of these factors can...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Is It Too Late To Consider Costco Wholesale (COST) After Its Strong Multi Year Rally?

Wondering whether Costco Wholesale at US$1,014.38 is priced for perfection or offering value can be an important question before committing fresh capital. The stock has posted returns of 2.8% over the last 7 days, 4.2% over 30 days, 18.7% year to date and 4.6% over the past year, with very large gains over 3 and 5 years at 110.8% and 186.2% respectively. Recent coverage has focused on Costco Wholesale as a major player in US consumer retail, often highlighting its membership model and scale...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

A Look At Alkermes (ALKS) Valuation As New Vibrance‑1 Narcolepsy Data Draws Investor Focus

Why new Vibrance-1 data matters for Alkermes (ALKS) investors Alkermes (ALKS) is back in focus after plans to present fresh Vibrance-1 phase 2 data on alixorexton in narcolepsy type 1 at the AAN 2026 meeting, alongside elevated options implied volatility. For you as a shareholder or potential buyer, this pairing of detailed clinical results and active options pricing highlights how closely the market is watching Alkermes’ neuroscience pipeline and upcoming information flow. See our latest...
WSE:ABS
WSE:ABSSoftware

Top European Dividend Stocks For April 2026

As European markets experience a positive shift, buoyed by corporate earnings and geopolitical de-escalation in the Middle East, investors are increasingly turning their attention to dividend stocks as a potential source of steady income amid economic uncertainties. In this environment, selecting dividend stocks with strong fundamentals and consistent payout histories can offer stability and resilience against market volatility.
NYSE:KGS
NYSE:KGSEnergy Services

Is It Too Late To Consider Kodiak Gas Services (KGS) After A 96% One Year Surge?

Deciding whether Kodiak Gas Services at around US$64.82 is still a sensible entry point, or whether the market has already priced in the story, starts with understanding how its current share price lines up against its fundamentals. The stock has moved recently, with returns of 4.1% over 7 days, 9.6% over 30 days, 72.2% year to date and 95.8% over the past year, which may change how you think about both potential and risk. Recent coverage has focused on Kodiak Gas Services as part of broader...
NasdaqGS:KALU
NasdaqGS:KALUMetals and Mining

Kaiser Aluminum (KALU) Margin Gains Sustain EPS Strength And Test Bearish Narratives

Kaiser Aluminum (KALU) just posted another set of quarterly numbers, with Q4 2025 revenue at US$929 million and basic EPS of US$1.74, alongside trailing twelve month revenue of about US$3.4 billion and EPS of US$6.96. The company has seen revenue move from US$765.4 million in Q4 2024 to US$929 million in Q4 2025, while quarterly EPS shifted from US$1.23 to US$1.74 over the same period. Investors may weigh those headline gains against a net income line that reached US$28.2 million in the...
TSX:CHP.UN
TSX:CHP.UNRetail REITs

Is Choice Properties REIT (TSX:CHP.UN) Attractive After Recent Gains And DCF Fair Value Check

Wondering if Choice Properties Real Estate Investment Trust is fairly priced at its current level, or if the market is missing something about its long term potential. The unit price recently closed at C$15.48, with returns of 4.2% year to date and 10.9% over the last year, so recent moves may have changed how the market is viewing risk and reward. Recent news has focused on Choice Properties as a large Canadian REIT with a portfolio anchored by necessity based retail. This can influence how...
NYSE:NEU
NYSE:NEUChemicals

NewMarket (NEU) Margin Decline Challenges Bullish Narratives After Strong Q1 EPS

NewMarket (NEU) opened 2026 with Q1 revenue of US$669.7 million and basic EPS of US$12.62, setting the tone for how the year might shape up against its recent track record. Over the past year, the company has seen trailing twelve month revenue sit at about US$2.7 billion and basic EPS at US$43.77, giving investors a clearer view of the earnings power behind the latest quarterly print. With a trailing net profit margin of 15.2% compared with last year’s 17.2%, the story this quarter is focused...
TSX:BYD
TSX:BYDCommercial Services

Is It Time To Reconsider Boyd Group Services (TSX:BYD) After Its Recent Share Price Slide

Wondering whether Boyd Group Services at around C$162.65 is pricing in too much hope or not enough? This article walks through what that means for you as a potential or current shareholder. The stock has seen a 2.2% decline over the last 7 days, a 15.5% decline over the past month, and is down 24.8% year to date, with a 20.2% decline over 1 year and around 27% over 3 and 5 years. Recent coverage has focused on Boyd Group Services as analysts and investors reassess expectations after this...
NYSE:A
NYSE:ALife Sciences

Does Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues?

Recently, Axion BioSystems announced that it had reached a confidential settlement with Agilent Technologies to fully resolve two Delaware lawsuits, with neither party admitting liability and Axion continuing to market and develop its product line. At the same time, industry research highlights Agilent as an important provider in the expanding Cloud Electronic Laboratory Notebook market, where digitalization and compliance needs are driving broader adoption of cloud-based lab data...
NYSE:RDW
NYSE:RDWAerospace & Defense

Redwire Commanders Deal Puts Drone Profile And Valuation In Focus

Redwire (NYSE:RDW) has entered a multi year marketing partnership with the Washington Commanders. The company will act as a Drone Technology Partner while supporting U.S. service members, veterans, and their families. The agreement includes a high visibility campaign in a major U.S. media market aimed at raising brand awareness. Redwire, trading at $10.04, is adding a consumer facing element to its defense technology profile through this partnership with the Washington Commanders. After a...
NYSE:USFD
NYSE:USFDConsumer Retailing

How Investors May Respond To US Foods (USFD) Zacks Upgrade Tied To Earnings Estimate Momentum

Earlier this week, Zacks upgraded US Foods Holding to a Rank #2 (Buy), citing rising optimism around the company’s earnings prospects and underlying business performance. The upgrade is grounded in an upward trend in earnings estimates, highlighting how analyst expectations for profitability are shifting as the company executes its growth initiatives. We’ll now examine how this earnings-driven upgrade interacts with US Foods’ existing investment narrative, particularly its focus on margin...
TSX:DSV
TSX:DSVMetals and Mining

Discovery Silver Deepens Timmins Footprint With Abitibi Stake And Kidd Expansion

Discovery Silver entered a participation agreement to acquire a significant stake in Abitibi Metals, securing rights to maintain its position and exposure to exploration upside. The company completed the acquisition of Glencore's Kidd operations, expanding the Porcupine area footprint and associated infrastructure. Ticker TSX:DSV last closed at CA$9.37, with the share price up 11.3% year to date and 264.6% over the past year. For investors tracking TSX:DSV, these moves follow a very large 3...
NYSE:LEA
NYSE:LEAAuto Components

Assessing Lear (LEA) Valuation After A Strong 1 Year Share Price Surge

Key business mix and revenue profile Lear (LEA) generates its revenue from two main segments, Seating and E-Systems. Together, these segments account for nearly all of its reported sales and shape how investors tend to think about the business. The Seating segment contributes about US$17.3b in revenue, while E-Systems adds roughly US$6.2b, with a small negative contribution from other items. This tilt toward Seating reflects Lear’s exposure to vehicle production volumes and content choices by...
TSX:CHE.UN
TSX:CHE.UNChemicals

April 2026's Global Undervalued Small Caps With Insider Buying

As global markets continue to rally, buoyed by easing geopolitical tensions in the Middle East and positive economic indicators, small-cap stocks have shown resilience with the Russell 2000 index posting significant gains. In this dynamic environment, identifying undervalued small-cap companies with insider buying can offer unique opportunities for investors looking to capitalize on potential growth while navigating current market conditions.
TSE:5344
TSE:5344Electronic

High Growth Tech Stocks to Watch in April 2026

In April 2026, global markets are experiencing strong upward momentum, fueled by de-escalating geopolitical tensions in the Middle East and positive economic indicators from major regions like the U.S. and China. As key indices such as the Nasdaq Composite and Russell 2000 reach record highs, investors are increasingly focused on high-growth tech stocks that demonstrate robust earnings potential and innovation-driven growth, making them attractive in this buoyant market environment.
NYSE:INSP
NYSE:INSPMedical Equipment

A Look At Inspire Medical Systems (INSP) Valuation After Recent Share Price Reset

Recent share performance and business snapshot With no single headline event driving Inspire Medical Systems (INSP) today, attention turns to how the stock’s recent performance and business profile line up for investors watching the name. The share price closed at US$56.35, with a 1 day return of 4.0%, a flat move over the past week, an 8.2% gain over the past month, and a 29.0% decline over the past 3 months. Over longer periods, total returns have been negative, including a 38.9% decline...
KOSE:A071970
KOSE:A071970Machinery

April 2026's Global Stocks Estimated Below Intrinsic Value

As global markets rally on the back of positive developments in the Middle East and encouraging economic data, investors are increasingly optimistic about future growth prospects. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for those looking to capitalize on market inefficiencies.
NYSE:NOC
NYSE:NOCAerospace & Defense

Is Northrop Grumman (NOC) Reframing Its Defense Edge Through AI-Driven Space Ops And B-21 Acceleration?

In April 2026, Northrop Grumman reported first-quarter revenue of US$9.88 billion and net income of US$875 million, while also advancing the B-21 Raider test campaign and accelerating its production plans. The company’s collaboration with Flexcompute on AI-powered real-time thruster impingement prediction, built on NVIDIA Physics NeMo, highlights how it is integrating advanced physics-informed AI to compress mission preparation timelines and support more efficient, uncertainty-aware space...
NYSE:BA
NYSE:BAAerospace & Defense

Boeing (BA) Q1 Loss And One Off Driven EPS Challenge Bullish Profitability Narratives

Boeing (BA) opened 2026 with Q1 revenue of US$22.2b and a basic EPS loss of US$0.11, as net income excluding extra items came in at a loss of US$90m. Over the past six reported quarters, revenue has moved from US$15.2b in Q4 2024 to a range between US$19.5b and US$24.0b through 2025. Quarterly EPS has swung between a loss of US$7.14 and a profit of US$10.59, which places greater focus on margins and reported profitability than on the headline revenue line. See our full analysis for...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Is Regeneron Pharmaceuticals (REGN) Still Attractive After Recent Share Price Strength?

If you are wondering whether Regeneron Pharmaceuticals at around US$766 per share still offers value, the answer depends on how you look at what the market is pricing in today. The stock recently closed at US$766.02, with returns of 2.7% over 7 days, 3.3% over 30 days, a 1.3% decline year to date, and 28.4% over the last year, which gives you a mixed snapshot of recent sentiment. Alongside these moves, investors have been tracking broader sector developments and company specific updates that...
SHSE:688519
SHSE:688519Electronic

Global Growth Companies With High Insider Ownership In April 2026

As global markets continue to rally, buoyed by easing geopolitical tensions in the Middle East and strong earnings reports, investors are keenly observing the performance of major indices like the Nasdaq Composite and S&P 500, which have recently hit record highs. In this environment of optimism and growth, companies with high insider ownership often attract interest due to their potential for aligned interests between management and shareholders, making them noteworthy candidates for those...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Has The Market Mispriced Jack Henry And Associates (JKHY) After Its Recent Share Price Weakness

If you are wondering whether Jack Henry & Associates is fairly priced or offering value right now, the recent share performance gives you a starting point but not the full story. The stock last closed at US$150.60, with returns of a 2.3% decline over 7 days, a 5.2% decline over 30 days, a 15.6% decline year to date, an 11.5% decline over 1 year, a 1.8% decline over 3 years, and a 2.3% decline over 5 years. These figures can shape how investors currently view its potential and risk. Recent...